Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease

被引:95
|
作者
Balducci, Chiara
Pierguidi, Laura
Persichetti, Emanuele
Parnetti, Lucilla
Sbaragli, Michele
Tassi, Carmelo
Orlacchio, Aldo
Calabresi, Paolo
Beccari, Tommaso
Rossi, Aroldo
机构
[1] Univ Perugia, Dipartimento Med Interna, I-06126 Perugia, Italy
[2] Univ Perugia, Neurol Clin, Osped Santa Maria della Misericordia, I-06126 Perugia, Italy
[3] Fdn Santa Lucia, IRCCS, Rome, Italy
[4] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, I-06126 Perugia, Italy
关键词
Parkinson's disease; beta-glucocerebrosidase; alpha-mannosidase; beta-mannosidase; beta-hexosaminidase;
D O I
10.1002/mds.21399
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent studies have shown a genetic association between glucocerebrosidase deficiencies and Parkinson's disease (PD). To further explore this issue the activity of beta-glucocerebrosidase and the activities of other lysosomal enzymes, alpha-mannosidase, beta-mannosidase, beta-hexosaminidase, and beta-galactosidase have been evaluated in the cerebrospinal fluid (CSF) of PD patients. The activities of alpha-mannosidase, beta-mannosidase, beta-glueocerebrosidase, and beta-hexosaminidase were substantially decreased in the CSF of PD patients, while levels of beta-galactosidase were essentially identical to controls. This study indicates that in PD several lysosomal hydrolases have decreased activities, further supporting a possible link between pathophysiological mechanisms underlying PD and lysosomal hydrolases. (c) 2007 Movement Disorder Society.
引用
收藏
页码:1481 / 1484
页数:4
相关论文
共 50 条
  • [42] Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease
    F. J. Jiménez-Jiménez
    J. A. Molina
    M. V. Aguilar
    I. Meseguer
    C. J. Mateos-Vega
    M. J. González-Muñoz
    F. de Bustos
    A. Martínez-Salio
    M. Ortí-Pareja
    M. Zurdo
    M. C. Martínez-Para
    Journal of Neural Transmission, 1998, 105 : 497 - 505
  • [43] Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's disease
    Lingor, P.
    Leha, A.
    Michalke, B.
    Boerger, M.
    Baehr, M.
    Zerr, I.
    Maass, F.
    MOVEMENT DISORDERS, 2017, 32
  • [44] Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease
    Melissa S. Rotunno
    Monica Lane
    Wenfei Zhang
    Pavlina Wolf
    Petra Oliva
    Catherine Viel
    Anne-Marie Wills
    Roy N. Alcalay
    Clemens R. Scherzer
    Lamya S. Shihabuddin
    Kate Zhang
    S. Pablo Sardi
    Scientific Reports, 10
  • [45] Cerebrospinal fluid protein markers of cognition in early Parkinson's disease
    Markaki, I.
    Bergstrom, S.
    Tsitsi, P.
    Remnestal, J.
    Manberg, A.
    Hertz, E.
    Paslawski, W.
    Uhlen, M.
    Mangone, G.
    Carvalho, S.
    Rascol, O.
    Meissner, W.
    Magnin, E.
    Wullner, U.
    Corvol, J. C.
    Nilsson, P.
    Svenningsson, P.
    MOVEMENT DISORDERS, 2020, 35 : S178 - S178
  • [46] A comparative study on neurochemistry of cerebrospinal fluid in advanced Parkinson's disease
    Liu, H
    Iacono, RP
    Schoonenberg, T
    Kuniyoshi, S
    Buchholz, J
    NEUROBIOLOGY OF DISEASE, 1999, 6 (01) : 35 - 42
  • [47] Associations between cerebrospinal fluid proteins and cytokines in Parkinson's disease
    Wijeyekoon, R.
    Moore, S.
    Farrell, K.
    Breen, D.
    Barker, R.
    Williams-Gray, C. H.
    MOVEMENT DISORDERS, 2016, 31 : S268 - S268
  • [48] Ceruloplasmin functional changes in Parkinson's disease-cerebrospinal fluid
    Barbariga, Marco
    Curnis, Flavio
    Andolfo, Annapaola
    Zanardi, Alan
    Lazzaro, Massimo
    Conti, Antonio
    Magnani, Giuseppe
    Volonte, Maria Antonietta
    Ferrari, Laura
    Comi, Giancarlo
    Corti, Angelo
    Alessio, Massimo
    MOLECULAR NEURODEGENERATION, 2015, 10
  • [49] Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
    Marco Barbariga
    Flavio Curnis
    Annapaola Andolfo
    Alan Zanardi
    Massimo Lazzaro
    Antonio Conti
    Giuseppe Magnani
    Maria Antonietta Volontè
    Laura Ferrari
    Giancarlo Comi
    Angelo Corti
    Massimo Alessio
    Molecular Neurodegeneration, 10
  • [50] Cerebrospinal Fluid β-Glucocerebrosidase Activity Is Reduced in Parkinson's Disease Patients
    Parnetti, Lucilla
    Paciotti, Silvia
    Eusebi, Paolo
    Dardis, Andrea
    Zampieri, Stefania
    Chiasserini, Davide
    Tasegian, Anna
    Tambasco, Nicola
    Bembi, Bruno
    Calabresi, Paolo
    Beccari, Tommaso
    MOVEMENT DISORDERS, 2017, 32 (10) : 1423 - 1431